347 related articles for article (PubMed ID: 22959551)
1. The promise of novel direct oral anticoagulants.
Hoffman R; Brenner B
Best Pract Res Clin Haematol; 2012 Sep; 25(3):351-60. PubMed ID: 22959551
[TBL] [Abstract][Full Text] [Related]
2. Old versus new anticoagulants: focus on pharmacology.
Benmira S; Banda ZK; Bhattacharya V
Recent Pat Cardiovasc Drug Discov; 2010 Jun; 5(2):120-37. PubMed ID: 20337579
[TBL] [Abstract][Full Text] [Related]
3. New oral anticoagulants: should they replace heparins and warfarin?
Tsiara S; Pappas K; Boutsis D; Laffan M
Hellenic J Cardiol; 2011; 52(1):52-67. PubMed ID: 21292607
[No Abstract] [Full Text] [Related]
4. Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism.
Eriksson BI; Quinlan DJ; Eikelboom JW
Annu Rev Med; 2011; 62():41-57. PubMed ID: 21226611
[TBL] [Abstract][Full Text] [Related]
5. Beyond unfractionated heparin and warfarin: current and future advances.
Hirsh J; O'Donnell M; Eikelboom JW
Circulation; 2007 Jul; 116(5):552-60. PubMed ID: 17664384
[No Abstract] [Full Text] [Related]
6. Overview of the new oral anticoagulants: opportunities and challenges.
Yeh CH; Hogg K; Weitz JI
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1056-65. PubMed ID: 25792448
[TBL] [Abstract][Full Text] [Related]
7. New oral anticoagulants for the treatment of venous thromboembolism.
Agnelli G; Becattini C; Franco L
Best Pract Res Clin Haematol; 2013 Jun; 26(2):151-61. PubMed ID: 23953903
[TBL] [Abstract][Full Text] [Related]
8. New anticoagulants for the prevention of thromboembolism.
Lepic K; Crowther M
Curr Pharm Des; 2010; 16(31):3472-4. PubMed ID: 20858184
[TBL] [Abstract][Full Text] [Related]
9. Changing practice of anticoagulation: will target-specific anticoagulants replace warfarin?
Arepally GM; Ortel TL
Annu Rev Med; 2015; 66():241-53. PubMed ID: 25587651
[TBL] [Abstract][Full Text] [Related]
10. Novel oral anticoagulants in development: Dabigatran, Rivaroxaban, and Apixaban.
Sattari M; Lowenthal DT
Am J Ther; 2011 Jul; 18(4):332-8. PubMed ID: 20535013
[TBL] [Abstract][Full Text] [Related]
11. Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxaban.
Morell J; Sullivan B; Khalabuda M; McBride BF
J Clin Pharmacol; 2010 Sep; 50(9):986-1000. PubMed ID: 20124518
[TBL] [Abstract][Full Text] [Related]
12. Rivaroxaban for the prevention and treatment of venous thromboembolism.
Turpie AG
Fundam Clin Pharmacol; 2012 Feb; 26(1):33-8. PubMed ID: 21851388
[TBL] [Abstract][Full Text] [Related]
13. [New anticoagulants: dabigatran, rivaroxaban and apixaban].
Vargas Ruiz AG; Ramírez López AN; Medina Viramontes ME
Gac Med Mex; 2012; 148(3):257-64. PubMed ID: 22820359
[TBL] [Abstract][Full Text] [Related]
14. Practical management of new oral anticoagulants after total hip or total knee arthroplasty.
Klauser W; Dütsch M
Musculoskelet Surg; 2013 Dec; 97(3):189-97. PubMed ID: 24249360
[TBL] [Abstract][Full Text] [Related]
15. [Clinical management of the new anticoagulants].
Zapata Wainberg G; Ximénez-Carrillo Rico A; Vivancos Mora J
Neurologia; 2012 Mar; 27 Suppl 1():33-8. PubMed ID: 22682208
[TBL] [Abstract][Full Text] [Related]
16. Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal.
Bauer KA
Stroke; 2013 Jun; 44(6 Suppl 1):S38-40. PubMed ID: 23709725
[No Abstract] [Full Text] [Related]
17. Inhibitory effect of apixaban compared with rivaroxaban and dabigatran on thrombin generation assay.
Wong PC; White A; Luettgen J
Hosp Pract (1995); 2013 Feb; 41(1):19-25. PubMed ID: 23466964
[TBL] [Abstract][Full Text] [Related]
18. [Thromboembolic prophylaxis 2011: is warfarin on the wane?].
Di Pasquale G; Riva L
G Ital Cardiol (Rome); 2011 Sep; 12(9):556-65. PubMed ID: 21892216
[TBL] [Abstract][Full Text] [Related]
19. [Large studies of NOAC shows good and safe stroke protection].
Hijazi Z; Oldgren J
Lakartidningen; 2015 Sep; 112():. PubMed ID: 26348046
[No Abstract] [Full Text] [Related]
20. ["Xa-tra-xa": opportunities and open questions about new anticoagulants].
Beer JH
Praxis (Bern 1994); 2011 Aug; 100(16):947. PubMed ID: 21910293
[No Abstract] [Full Text] [Related]
[Next] [New Search]
